Review Article Impact of evolution of molecular technologies on evaluation of Neuromuscular Disorders in India at a Centre in Mumbai. : Impact of evolution of molecular technologies on evaluation of Neuromuscular Disorders in India at a Centre in Mumbai.

Rashna S Dastur; Satish V Khadilkar

doi:10.15713/ins.bhj.80

Authors

Rashna S Dastur Director, Centre for Advanced Molecular Diagnostics in Neuromuscular Disorders (CAMDND), c/o IATRIS (TDM Lab), Plot No. 194, Scheme No. 6, Road No. 15, Sion (East), Mumbai-400022, India.
Dr. Satish V Khadilkar Professor of Neurology, Dean of Bombay Hospital, Department of Neurology, Bombay Hospital Trust, Mumbai, India

DOI:

https://doi.org/10.15713/ins.bhj.80

Keywords:

Molecular Genetics, Neuromuscular, NGS, PCR, LGMD.

Abstract

Abstract:

Advances in molecular methods has made genetic testing as an imperative parameter, to be used in research studies and clinical practice. The present article includes the evolution of Molecular Diagnostic techniques over a period of two decades leading to the corresponding expansion in identification & classification of various Neuromuscular disorders in the population of mainly Western India.

Initially conventional testing was done by mPCR, RFLP-PCR for single gene disorders like DMD/BMD & SMA respectively; followed by MLPA technique, for deletion duplication analysis. Under a research study, immuno-specific Western Blot was used for protein analysis as an initial screening tool for LGMD2B. Sangers sequencing was done for single gene (for a few LGMD2B cases) & known familial variants of LGMD2B & LGMD2A and GNE myopathy. Availability of Next generation sequencing technique involving massive parallel sequencing of multiple genes, improved the possibility of identifying the disease causing/ pathogenic mutations in phenotypically overlapping NMDs like LGMDs and Hereditary Neuropathies.

Since last 12 years, over 2,600 patients from mainly western India have been analysed for various neuromuscular disorders. Carrier status of relatives of the probands was also determined in many of the cases. These molecular technologies have enabled to attained definitive diagnosis of different neuromuscular disorders in India. The diagnostic and predictive data generated helps in better management of the disease. It also has immense relevance in carrier and prenatal testing for the families at risk, thereby limiting the occurrence of the diseases in the population.

Author Biography

Dr. Satish V Khadilkar, Professor of Neurology, Dean of Bombay Hospital, Department of Neurology, Bombay Hospital Trust, Mumbai, India

Professor of Neurology,

Dean of Bombay Hospital,

Department of Neurology, Bombay Hospital Trust,

Mumbai, India

References

Khadilkar S. Bird's eye view of myopathies in India. Neurol India 2008; 56:225-8

Nalini A, Polavarapu K, Preethish-Kumar V. Muscular dystrophies: An Indian scenario. Neurol India 2017; 65:969-70

Emery AE, Muntoni F, Quinlivan RC. Duchenne muscular dystrophy. 4th edition, Oxford: Oxford University Press; 2015.

Worton RG, Thompson MW. Genetics of Duchenne muscular dystrophy. Annu Rev Genet. 1988; 22:601-29

Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990 Nov; 86(1):45-8. doi: 10.1007/BF00205170. PMID: 2253937.

Chamberlain JS, Gibbs RA, Ranier JE, Caskey CT. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy. In: PCR Protocols: A Guide to Methods and Applications (Eds; MA Innis, DH Gelfand, JJ Sninsky, TJ White), Academic Press, San Diego (USA). 1990. p 272-281.

Dastur RS, Gaitonde PS, Khadilkar SV, Nadkarni JJ. Becker muscular dystrophy in Indian patients: analysis of dystrophin gene deletion patterns. Neurol India. 2008 Jul-Sep; 56(3):374-8. doi: 10.4103/0028-3886.40961. PMID: 18974567.

Kohli S, Saxena R, Thomas E, Singh J, Verma IC. Gene changes in Duchenne muscular dystrophy: Comparison of multiplex PCR and multiplex ligation-dependent probe amplification techniques. Neurol India 2010; 58:852-6

Nadkarni JJ, Dastur RS, Viswanathan V, Gaitonde PS, Khadilkar SV. Duchenne and Becker muscular dystrophies: an Indian update on genetics and rehabilitation. Neurol India. 2008 Jul-Sep; 56(3):248-53. doi: 10.4103/0028-3886.43442. PMID: 18974550.

Singh RJ, Manjunath M, Preethish-Kumar V, Polavarapu K, Vengalil S, Thomas PT, Thennarasu K, Gayathri N, Sekar D, Nashi S, Nalini A. Natural history of a cohort of Duchenne muscular dystrophy children seen between 1998 and 2014: An observational study from South India. Neurol India 2018; 66:77-82

Dastur RS, Kachwala MY, Khadilkar SV, Hegde MR, Gaitonde PS. Identification of deletions and duplications in the Duchenne muscular dystrophy gene and female carrier status in western India using combined methods of multiplex polymerase chain reaction and multiplex ligation-dependent probe amplification. Neurol India. 2011 Nov-Dec; 59(6):803-9. doi: 10.4103/0028-3886.91355. PMID: 22234189.

Melki J, Abdelhak S, Sheth P, Bachelot MF, Burlet P, Marcadet A, et al. Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 1990; 44:767-8.

Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy - determining gene. Cell 1995; 80:155-65.

Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN 1 from the copy gene SMN2. Hum Mol Genet 1999; 8:1177-83.

Dastur RS, Gaitonde PS, Khadilkar SV, Udani VP, Nadkarni JJ. Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients. Neurol India. 2006 Sep; 54(3):255-9. doi: 10.4103/0028-3886.27147. PMID: 16936383.

Niba ETE, Rochmah MA, Harahap NIF, Awano H, Morioka I, Iijima K, Takeshima Y, Saito T, Saito K, Takeuchi A, Lai PS, Bouike Y, Matsuo M, Nishio H, Shinohara M. Spinal Muscular Atrophy: Advanced Version of Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion. Kobe J Med Sci. 2019 Jul 16; 65(2):E49-E53. PMID: 31956256; PMCID: PMC7012194.

Khadilkar SV, Singh RK. Nusinersen and spinal muscular atrophies: Where are we in 2020? Ann Indian Acad Neurol 2020;23:743-4

Paulson, Henry L. “The spinocerebellar ataxias.” Journal of neuro-ophthalmology: the official journal of the North American Neuro-Ophthalmology Society 2009; vol. 29,3 (2009): 227-37. doi:10.1097/WNO0b013e3181b416de

Venkatesh SD, Kandasamy M, Moily NS, Vaidyanathan R, Kota LN, Adhikarla S, Yadav R, Pal PK, Jain S, Purushottam M. Genetic testing for clinically suspected spinocerebellar ataxias: report from a tertiary referral centre in India. J Genet. 2018 Mar; 97(1):219-224. PMID: 29666341.

Choudhury S, Chatterjee S, Chatterjee K, Banerjee R, Humby J, Mondal B, Anand SS, Shubham S, Kumar H. Clinical Characterization of Genetically Diagnosed Cases of Spinocerebellar Ataxia Type 12 from India. Mov Disord Clin Pract. 2017 Nov 1; 5(1):39-46. doi: 10.1002/mdc3.12551. PMID: 30363072; PMCID: PMC6090588.

Khadilkar SV, Faldu HD, Patil SB and Singh R, Limb-girdle Muscular Dystrophies in India: A Review. Annals of Indian Academy of Neurology. 2017 Apr-Jun; 20(2):87-95. doi: 10.4103/aian.AIAN_81_17.

Ankala A, Kohn JN, Dastur R, Gaitonde P, Khadilkar SV, Hegde MR. Ancestral founder mutations in calpain-3 in the Indian Agarwal community: historical, clinical, and molecular perspective. Muscle Nerve. 2013 Jun; 47(6):931-7. doi: 10.1002/mus.23763. Epub 2013 May 11. PMID: 23666804.

Khadilkar SV, Chaudhari CR, Dastur RS, Gaitonde PS, Yadav JG. Limb-girdle muscular dystrophy in the Agarwals: Utility of founder mutations in CAPN3 gene. Ann Indian Acad Neurol 2016; 19:108-11

Dastur RS, Gaitonde PS, Kachwala M, Nallamilli BRR, Ankala A, Khadilkar SV, et al. Detection of Dysferlin Gene Pathogenic Variants in the Indian Population in Patients Predicted to have a Dysferlinopathy Using a Blood-based Monocyte Assay and Clinical Algorithm: A Model for Accurate and Cost-effective Diagnosis, Annals of Indian Academy of Neurology, 2017 Jul-Sep; 20(3):302-308. doi: 10.4103/aian.AIAN_129_17.

Nallamilli BRR, Chakravorty S, Kesari A, Tanner A, Ankala A, Schneider T, da Silva , Beadling R et al. Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Annals of Clinical Translational Neurology, 2018 Dec 1; 5(12):1574-1587. doi: 10.1002/acn3.649. eCollection 2018 Dec.

Eisenberg I, Avidan N, Potikha T, Hochner H, Chen M, Olender T, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001; 29:83-7.

Khadilkar SV, Nallamilli BR, Bhutada A, Hegde M, Gandhi K, Faldu HD, et al. A report on GNE myopathy: Individuals of Rajasthan ancestry share the Roma gene. J Neurol Sci 2017; 375:239-40.

Nalini A, Gayathri N, Nishino I, Hayashi YK. GNE myopathy in India. Neurol India 2013; 61:371-4.

Ilyas M: Next-Generation Sequencing in Diagnostic Pathology. Pathobiology 2017; 84:292-305. doi: 10.1159/000480089

Shieh PB. Muscular dystrophies and other genetic myopathies. NeurolClin. 2013; 31(4):1009-29.

Bushby KM. The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms. Hum Mol Genet 1999; 8: 1875– 1882.

González-Jamett AM, Bevilacqua JA and Díaz AMC, Hereditary Myopathies, Muscle Cell and Tissue - Current Status of Research Field 2018; DOI: 10.5772/intechopen.76076

Khadilkar S V, Singh R K, Katrak S M. Sarcoglycanopathies : a report of 25 cases. Neurol India 2002; 50:27-32

Nalini A, Gayathri N, Thaha F, Das S, Shylashree S. Sarcoglycanopathy: Clinical and histochemical characteristics in 66 patients. Neurol India 2010;58:691-6

Khadilkar SV, Singh RK, Hegde M, Urtizberea A, Love DR, Chong B. Spectrum of mutations in sarcoglycan genes in the Mumbai region of western India: high prevalence of 525del T. Neurol India. 2009 Jul-Aug; 57(4):406-10. doi: 10.4103/0028-3886.55603. PMID: 19770540.

Chakravorty S, Nallamilli BRR, Khadilkar SV, Singla MB, Bhutada A, Dastur R et al. Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent. Front Neurol. 2020 Nov 5; 11:559327. doi: 10.3389/fneur.2020.559327. PMID: 33250842; PMCID: PMC7674836.

Tazir M, Hamadouche T, Nouioua S, Mathis S, Vallat JM. Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update. J Neurol Sci. 2014 Dec 15; 347(1-2):14-22. doi: 10.1016/j.jns.2014.10.013. Epub 2014 Oct 16. PMID: 25454638.

Nagappa M, Sharma S, Govindaraj P, Chickabasaviah YT, Siram R, Shroti A et al. PMP22 Gene-Associated Neuropathies: Phenotypic Spectrum in a Cohort from India. J Mol Neurosci. 2020 May; 70(5):778-789. doi: 10.1007/s12031-020-01488-w. Epub 2020 Jan 28. PMID: 31993930.

Lemmers RJ, van der Wielen MJ, Bakker E, Frants RR, van der Maarel SM. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2006 Oct; 16(9-10):615-7; author reply 617-8. doi: 10.1016/j.nmd.2006.07.013. Epub 2006 Aug 28. PMID: 16938455.

Tamhankar PM, Phadke SR. Clinical profile and molecular diagnosis in patients of facioscapulohumeral dystrophy from Indian subcontinent. Neurol India 2010; 58:436-40